Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuropsychopharmacology

• Publication date

  2018-04-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/s41386-018-0067-zPMID 29728649PMCID PMC6046036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.

  2017cited by this paper
• Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease

  2017cited by this paper
• Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.

  2017cited by this paper
• Behavioral Deficits Following Withdrawal from Chronic Ethanol Are Influenced by SLO Channel Function in Caenorhabditis elegans

  2017cited by this paper
• Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.

  2017cited by this paper
• The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum

  2017cited by this paper
• Identification of the gene that codes for the σ2 receptor

  2017cited by this paper
• Sigma Receptors and Substance Use Disorders.

  2017cited by this paper
• Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype‐Selective Ligands

  2016cited by this paper
• The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain Cells

  2016cited by this paper
• Drosophila and Caenorhabditis elegans as Discovery Platforms for Genes Involved in Human Alcohol Use Disorder.

  2015cited by this paper
• Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III.

  2015cited by this paper
• Alcohol use disorders: tracts, twins, and trajectories.

  2015cited by this paper
• The role of the BK channel in ethanol response behaviors: evidence from model organism and human studies

  2014cited by this paper
• Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

  2014cited by this paper
• Neurochemical mechanisms of alcohol withdrawal.

  2014cited by this paper
• Evolution of a strategy for preparing bioactive small molecules by sequential multicomponent assembly processes, cyclizations, and diversification.

  2014cited by this paper
• Changes in emotional reactivity and distress tolerance among heavy drinking adolescents during sustained abstinence.

  2014cited by this paper
• mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats.

  2013cited by this paper
• Ethanol metabolism and osmolarity modify behavioral responses to ethanol in C. elegans.

  2012cited by this paper
• Expedient synthesis of norbenzomorphan library via multicomponent assembly process coupled with ring-closing reactions.

  2012cited by this paper
• The non-genomic rapid acidification in peripheral T cells by progesterone depends on intracellular calcium increase and not on Na+/H+-exchange inhibition.

  2012cited by this paper
• Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site

  2011cited by this paper
• Selective Toxicity of the Anthelmintic Emodepside Revealed by Heterologous Expression of Human KCNMA1 in Caenorhabditis elegans

  2011cited by this paper
• Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.

  2011cited by this paper
• Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain.

  2011cited by this paper
• Activation of σ-Receptors Induces Binge-like Drinking in Sardinian Alcohol-Preferring Rats

  2011cited by this paper
• Synthesis and Pharmacological Evaluation of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a Cocaine Antagonist, in Rodents

  2011cited by this paper
• Reinforcing Effects of σ-Receptor Agonists in Rats Trained to Self-Administer Cocaine

  2010cited by this paper
• A Differential Role for Neuropeptides in Acute and Chronic Adaptive Responses to Alcohol: Behavioural and Genetic Analysis in Caenorhabditis elegans

  2010cited by this paper
• PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.

  2009cited by this paper
• Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats.

  2009cited by this paper
• Neuropharmacology of alcohol addiction

  2008cited by this paper
• The sigma receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking

  2008cited by this paper
• Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.

  2008cited by this paper
• Effects of UMB24 and (±)-SM 21, putative σ2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice

  2007cited by this paper
• σ Receptors: Historical Perspective and Background

  2007cited by this paper
• Qualitative and Quantitative Analyses of Protein Phosphorylation in Naive and Stimulated Mouse Synaptosomal Preparations*S

  2007cited by this paper
• Progesterone receptor membrane component 1: an integrative review.

  2007cited by this paper
• A key role for corticotropin-releasing factor in alcohol dependence.

  2007cited by this paper
• Differential Effects of σ1 Receptor Blockade on Self-Administration and Conditioned Reinstatement Motivated by Cocaine vs Natural Reward

  2007cited by this paper
• Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.

  2007cited by this paper
• The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells.

  2006cited by this paper
• Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

  2006cited by this paper
• A small-molecule screen in C. elegans yields a new calcium channel antagonist

  2006cited by this paper
• Plasticity of reward neurocircuitry and the 'dark side' of drug addiction

  2005cited by this paper
• The "Ups and Downs" of Signaling Cascades in Addiction

  2005cited by this paper
• Laboratory models of alcoholism: treatment target identification and insight into mechanisms

  2005cited by this paper
• Involvement of sigma (σ) receptors in the acute actions of methamphetamine: Receptor binding and behavioral studies

  2005cited by this paper
• Caenorhabditis elegans VEM-1, a Novel Membrane Protein, Regulates the Guidance of Ventral Nerve Cord-Associated Axons

  2004cited by this paper
• Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure.

  2004cited by this paper
• Clinical trials with sigma ligands.

  2004cited by this paper
• The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

  2004cited by this paper
• Neurobiological correlates of the disposition and maintenance of alcoholism.

  2003cited by this paper
• The Community Reinforcement Approach.

  2003cited by this paper
• Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol

  2002cited by this paper
• Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

  2002cited by this paper
• Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity

  2002cited by this paper
• Opipramol for the Treatment of Generalized Anxiety Disorder: A Placebo-Controlled Trial Including an Alprazolam-Treated Group

  2001cited by this paper
• The use of functional genomics in C. elegans for studying human development and disease

  2001cited by this paper
• Excessive Ethanol Drinking Following a History of Dependence: Animal Model of Allostasis

  2000cited by this paper
• Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.

  2000cited by this paper
• Genome sequence of the nematode C. elegans: a platform for investigating biology.

  1998cited by this paper
• Genome sequence of the nematode C-elegans: A platform for investigating biology

  1998cited by this paper
• [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes.

  1997cited by this paper
• Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

  1996cited by this paper
• Genetic pharmacology: interactions between drugs and gene products in Caenorhabditis elegans.

  1995cited by this paper
• Alcohol and conscious level.

  1990cited by this paper
• Blood alcohol level among emergency room patients: a multivariate analysis.

  1989cited by this paper
• Extrachromosomal DNA transformation of Caenorhabditis elegans

  1985cited by this paper
• Blood ethanol levels in sober alcohol users seen in an emergency room.

  1981cited by this paper
• Unusually high levels of blood alcohol?

  1976cited by this paper

• Siramesine Attenuates Early Brain Injury Through the TMEM97/NPC1 Pathway After Experimental Subarachnoid Hemorrhage in Rats

  2025cites this paper
• Transmembrane Protein 97 (TMEM97): Molecular Target and Treatment in Age-Related Macular Degeneration (AMD)

  2025cites this paper
• Isolation and Bioassay of Linear Veraguamides from a Marine Cyanobacterium (Okeania sp.)

  2025cites this paper
• Isolation and Bioassay of Linear Veraguamides from a Marine Cyanobacterium (Okeania sp.)

  2025cites this paper
• Structure-Affinity relationships of novel σ2R/TMEM97 ligands.

  2024cites this paper
• Neuroprotective Effect of Sigma-2 Modulator CT2074 in a Mouse Model of Ocular Hypertension.

  2024cites this paper
• Discovery of WLB-89462, a New Drug-like and Highly Selective σ2 Receptor Ligand with Neuroprotective Properties.

  2023cites this paper
• Highly specific σ2R/TMEM97 ligand FEM-1689 alleviates neuropathic pain and inhibits the integrated stress response

  2023cites this paper
• GLP-1/Sigma/RAGE Receptors: An evolving picture of Alzheimer's Disease pathology and treatment.

  2023cites this paper
• Validation of σ 2 R/TMEM97 as a neuropathic pain target: Specificity, human expression and mechanism of action.

  2023cites this paper
• Structure-affinity relationships of stereoisomers of norbenzomorphan-derived σ2R/TMEM97 modulators.

  2023cites this paper
• Highly specific σ2R/TMEM97 ligand alleviates neuropathic pain and inhibits the integrated stress response

  2023cites this paper
• From Natural Behavior to Drug Screening: Invertebrates as Models to Study Mechanisms Associated with Alcohol Use Disorders.

  2023cites this paper
• Screening of σ2 Receptor Ligands and In Vivo Evaluation of 11C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ2 Receptor Brain PET Tracer.

  2022cites this paper
• Characterization of Sigma-2 Receptor—Specific Binding Sites Using [3H]DTG and [125I]RHM-4

  2022cites this paper
• σ2R/TMEM97 in retinal ganglion cell degeneration

  2022cites this paper
• Neuroprotective Effects of σ2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.

  2022cites this paper
• Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.

  2022cites this paper
• Targeting σ2R/TMEM97 with novel aminotetralins.

  2022cites this paper
• Bridging Known and Unknown Unknowns: From Natural Products and Their Mimics to Unmet Needs in Neuroscience.

  2022cites this paper
• Transcriptional analysis of the response of C. elegans to ethanol exposure

  2021cites this paper
• Crystal structures of the σ2 receptor template large-library docking for selective chemotypes active in vivo

  2021cites this paper
• Structures of the σ2 receptor enable docking for bioactive ligand discovery

  2021cites this paper
• Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ2R/TMEM97 ligands.

  2020cites this paper
• Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.

  2020cites this paper
• The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice.

  2020cites this paper
• Sigma-2 Receptor—A Potential Target for Cancer/Alzheimer’s Disease Treatment via Its Regulation of Cholesterol Homeostasis

  2020influential citation
• Sigma-2 Receptors: An Emerging Target for CNS PET Imaging Studies

  2020cites this paper
• BRD2 regulation of sigma-2 receptor upon cholesterol deprivation

  2020cites this paper
• Unravelling the mechanisms of behaviors associated with AUDs using flies and worms.

  2019cites this paper
• Exploring the σ2R/TMEM97 protein‐mediated neuroprotective pathway in a C. elegans Alzheimer’s Disease Model of Neurodegeneration

  2019cites this paper
• Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice

  2019cites this paper
• The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson’s Disease (PD) and Major Depressive Disorder (MDD)

  2019cites this paper
• Development of Tetrahydroindazole‐Based Potent and Selective Sigma‐2 Receptor Ligands

  2019cites this paper
• Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.

  2019cites this paper
• Allosteric modulation of sigma receptors by BH3 mimetics ABT‐737, ABT‐263 (Navitoclax) and ABT‐199 (Venetoclax)

  2019cites this paper
• Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands

  2019cites this paper
• Changes in Brain Wave Amplitude Due to Methadone Administration based P300 Similar Stimuli

  2019cites this paper
• Effects of Methadone Intake on Alpha and Theta Amplitude in Relaxing with Closed and Open Eyes Conditions

  2019cites this paper
• 3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT2B, 5-HT7, or σ1 Receptor Ligands.

  2019cites this paper
• Diversity-Oriented Synthesis of Bioactive Azaspirocycles

  2019cites this paper
• BRD2 regulation of sigma-2 receptor expression upon cytosolic cholesterol deprivation

  2019cites this paper
• Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.

  2018cites this paper